Orphazyme: Another regulatory milestone
Research Note
2020-05-22
10:28
Redeye gives a brief view of the news that Orphazyme has received its third US Fast Track Designation with its lead compound, arimoclomol.
AH
Anders Hedlund
Disclosures and disclaimers